Recently, Yang et al. (43) demonstrated that IFITM1 was essentially required for the progression of non-small cell lung cancer (NSCLC), both in vitro and in vivo and the silenced expression of IFITM1 significantly reduced the capacity of sphere-formation, invasion, and migration of NSCLC. Here, IFITM1 is linked to non-small cell lung carcinoma.